A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution

Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
12/2002
12/05/2002	US20020182193 Method of in vitro preconditioning healthy donor's myoblasts before transplantation thereof in compatible patients suffering of myopathies like muscular dystrophy, for improving transplantation success
12/05/2002	US20020182192 Administering bone marrow cells to the mammal, such as allogeneic cells or autologous cells engineered to express dystrophin or other gene products
12/05/2002	US20020182190 Microparticle protection of therapeutic agents
12/05/2002	US20020182188 Making by debulking a suspension of human liver tissue under conditions to remove mature cells, while retaining immature cells having markers for the expression of alpha-fetoprotein, and/or albumin
12/05/2002	US20020182187 Method of decreasing radiation or radio-mimetic chemotherapy for hematopoietic pluripotent cell engraftment
12/05/2002	US20020182186 Isolated bone marrow composition enriched with physiologically compatible stem cells
12/05/2002	US20020182182 Recombinant viral vector encoding a human very low density lipoprotein (VLDL) receptor, operatively linked to regulatory sequences directing expression in a hepatocyte; familial hypercholesterolemia or hyperlipidemia
12/05/2002	US20020179537 Separation of platelets from whole blood for use as a healant
12/05/2002	DE10126284A1 Using specific Escherichia coli strains to treat or prevent infection by enteroinvasive bacteria or related microorganisms
12/05/2002	DE10124820A1 Zusammensetzung und Verwendung von Substanzen zur Stabilisierung von schwefelhaltigen Aminosäuren im Blut Composition and use of substances for the stabilization of sulfur-containing amino acids in blood
12/05/2002	CA2452707A1 Treatment or replacement therapy using transgenic stem cells delivered to the gut
12/05/2002	CA2452154A1 Carbohydrate modifying agent and drinks containing the modifying agent
12/05/2002	CA2451838A1 Stem cell differentiation
12/05/2002	CA2449979A1 A method of purification of neural stem cells
12/05/2002	CA2448963A1 Pharmaceutical use for secreted bacterial effector proteins
12/05/2002	CA2448620A1 Vaccination against the feline immunodeficiency virus
12/05/2002	CA2448436A1 Eb matrix production from fetal tissues and its use for tissue repair
12/05/2002	CA2448109A1 Alternative splice forms of proteins as basis for multiple therapeutic modalities
12/04/2002	EP1262554A2 Defective packaging non-oncoviral vectors based on mpmv and hiv
12/04/2002	EP1262542A2 Process for making cells, tissues and organs
12/04/2002	EP1262541A1 Production of bioavailable folic acid
12/04/2002	EP1261711A2 Compositions and methods for diagnosis and therapy of malignant mesothelioma
12/04/2002	EP1261694A2 Pleuripotent stem cells generated from adipose tissue-derived stromal cells and uses thereof
12/04/2002	EP1261693A2 Hyperthermia and immunotherapy for leukemias, lymphomas, and solid tumors
12/04/2002	EP1261692A1 Methods and compositions for reconstruction of multilayered tissue structures
12/04/2002	EP1261644A2 Modulation of the activity of the endothelial cell surface receptor ecrtp/dep-1 in the regulation of angiogenesis
12/04/2002	EP1261639A2 Chondromodulin-i related peptide
12/04/2002	EP1261627A2 Antibodies against plasma cells
12/04/2002	EP1261379A2 Genetic modification of the lung as a portal for gene delivery
12/04/2002	EP1261369A2 Compositions and methods for tumor-targeted delivery of effector molecules
12/04/2002	EP1261357A1 Isolation and transplantation of retinal stem cells
12/04/2002	EP1018866B1 Compositions and methods for the preservation of living tissues
12/04/2002	EP0836643A4 Immunoprotective barrier for transplantation of cells
12/04/2002	EP0690915B1 Isolated nucleic acid molecules coding for tumor rejection antigen precursor mage-3 and uses thereof
12/04/2002	EP0517817B1 Inhibitors of catalytic antibodies
12/04/2002	CN1382485A Medicine for treating lumbar intervertebral disk protrusion and its preparing process
12/04/2002	CN1382474A Chinese medicine for treating periodontal disease and its preparing process and application
12/04/2002	CN1382463A Chinese-medicinal capsule for treating cardiovascular and cerebrovascular diseases
12/04/2002	CN1382452A Process for preparing medicinal pill able to kill spiroplasmavirus
12/04/2002	CN1382451A Application of bamboo rat's serum and medicine containing said serum
12/04/2002	CN1382450A Stem cell medicine for repairing damage of central nerve and its preparing process
12/04/2002	CN1095381C Medicine for treating gastropathy and its prepn. method
12/04/2002	CN1095379C Chinese medicine for detoxicating wound and its preparing process
12/04/2002	CN1095377C Medicine for treating skin ringworm and dermatitis and prepn. process
12/04/2002	CN1095376C Blood pressure reducing and fat reducing beverage and its prodn. method
12/04/2002	CN1095372C Chinese medicinal preparation for treating rheumatism and atrophic arthritis, and its prepn. method
12/04/2002	CN1095371C Capsule for treating bone diseases
12/04/2002	CN1095369C Capsule for treating wind-cold and wind-dampness syndrome
12/04/2002	CN1095368C Tea for beautifying face and reducing fat
12/04/2002	CN1095367C Prepn. method of liquid donkey-hide gelatin by zymohydrolysis
12/04/2002	CN1095348C Formula for health beverage of Chinese wood frog oil and making tech tthereof
12/04/2002	CA2384907A1 Methods and compositions relating to mek5 and cardiac hypertrophy and dilated cardiomyopathy
12/03/2002	US6489307 Reducing the level of transcription of beta 1-adrenoceptor polypeptide-specific mrna in a mammalian host cell, by administering oligonucleotide; reduces receptor expression; hypotensive effect
12/03/2002	US6489165 Chondrocyte-like cells useful for tissue engineering and methods
12/03/2002	US6489164 Isolation of cells from organ tissue using sonication
12/03/2002	US6488978 Anti-bacteria agent made from shell, and methods for purifying and desalinating water and for washing agricultural products with use thereof
12/03/2002	US6488860 Container having connecting line for receiving blood, filter for removing leukocytes
12/03/2002	CA2213198C Gene therapy by anti-tgf-b agents
12/03/2002	CA2126103C Transfection of lung via aerosolized transgene delivery
11/2002
11/29/2002	WO2001092476A2 In vitro tissue test system
11/29/2002	CA2410946A1 In vitro tissue test system
11/28/2002	WO2002095067A2 INTERFERON α-14 POLYMORPHISM
11/28/2002	WO2002095030A2 Modulation of cd200 receptors
11/28/2002	WO2002095026A1 Method of proliferating terminal differentiated cells and recombinant vector therefor
11/28/2002	WO2002095019A1 Removal of plasmin(ogen) from protein solutions
11/28/2002	WO2002095011A2 Inactivation of genes of the mep pathway
11/28/2002	WO2002095010A2 Human secreted proteins
11/28/2002	WO2002095006A2 Muscle-specific expression vectors
11/28/2002	WO2002094997A2 Transcriptional regulation of target genes
11/28/2002	WO2002094989A2 Retroviral vectors and methods of using same
11/28/2002	WO2002094739A2 Method and apparatus for reducing pathogens in a biological sample
11/28/2002	WO2002094344A2 Method and apparatus for removal of insulin binding proteins (ibp) from biological fluids
11/28/2002	WO2002094298A1 Traditional chinese medicine for treatment and prevention of cancer
11/28/2002	WO2002094296A1 Lipoteichoic acid from lactic acid bacteria and its use to modulate immune responses mediated by gram-negative bacteria, potential pathogenic gram-positive bacteria
11/28/2002	WO2002094295A2 Extract of vegetable origin and pharmaceutical compositions containing it, for the treatment of disorders caused by abnormal cell proliferation
11/28/2002	WO2002094248A2 Composition and use of substances for stabilising amino acids containing sulphur and/or for inhibiting the continuous formation of amino acids containing sulphur in a blood sample
11/28/2002	WO2002074345A3 Immune modulation by transduced hematopoietic stem cells expressing antigens and antigen-presenting cell regulatory molecules
11/28/2002	WO2002070563A3 Nuclear hormone receptor ligand binding domain
11/28/2002	WO2002066636A3 T cell receptor variants expressed in mesenchymal cells and uses thereof
11/28/2002	WO2002066619A9 Methods of treating inflammation, particularly diabetes
11/28/2002	WO2002062969A3 Cellular reprogramming in peptide hydrogel and uses thereof
11/28/2002	WO2002054065A3 Reversible mhc multimer staining for functional purification of antigen-specific t cells
11/28/2002	WO2002050304A3 Oncolytic virus
11/28/2002	WO2001096393A9 Nucleotide and amino acid sequences of oocyte factors for altering ovarian follicular growth in vivo or in vitro
11/28/2002	WO2001095919A3 A recombinant non-replicating virus expressing gm-csf and uses thereof to enhance immune responses
11/28/2002	WO2001018021A9 B7-like polynucleotides, polypeptides, and antibodies
11/28/2002	US20020177567 Comprising a HER-2/neu extracellular domain fused to a HER-2/neu phosphorylation domain, wherein the protein is capable of producing an immune response in a warm-blooded animal.
11/28/2002	US20020177552 Colon tumor proteins, immunogenic portions thereof, or polynucleotides that encode such portions; alternatively, antigen presenting cell that expresses a colon tumor protein, or a T cell that is specific for cells expressing such a
11/28/2002	US20020177228 Method for producing preparations of mature and immature pancreatic endocrine cells, the cell preparation and its use for treatment of diabetes mellitus
11/28/2002	US20020177225 Bio-screening methods and biomaterial thereof
11/28/2002	US20020177224 Tissue engineering enhanced by the transfer of a growth factor gene
11/28/2002	US20020177215 Methods for producing purified adenoviral vectors
11/28/2002	US20020177213 Tissue plasminogen activator-like protease
11/28/2002	US20020177176 Novel antibody composition for isolating human cells from human-murine chimeric hematopoietic cell suspensions
11/28/2002	US20020177118 Monochromatic fluid treatment systems
11/28/2002	US20020176904 Antiprotozal composition
11/28/2002	US20020176887 Methods of delivery of cetyl myristoleate
11/28/2002	US20020176869 Hepatitus A virus vaccines
11/28/2002	US20020176851 Aministering to mammal an effective amount of therapeutic cells, expressing a membrane-bound, proteinaceous chimeric receptor, capable recognizing and binding target cell or infective agent; antitumor therapy
11/28/2002	US20020176850 Immunotherapy of cancer with allogeneic lymphocytes

1 ... 935 936 937 938 939 940 941 942 943 944 945 946 947 948 949 950 951 952 953 954 955 ... 1259